%20(2).png){kind=logo}
Join Ostro's Andrea Goudie as she explores AI-powered engagement and the past, present, and exciting future of digital marketing in life sciences.
Inside Chase Feiger's newest Forbes piece, he sits down with Giles Platford, President of the Takeda Plasma-Derived Therapies Business Unit, to discuss the challenges and breakthroughs shaping the future of PDTs.
Ostro, a leader in AI-driven digital engagement solutions, is proud to spotlight its partnership with the Desmoid Tumor Research Foundation (DTRF) as we approach Rare Disease Month, a meaningful time to foster awareness and champion impactful innovation.
AI can transform pharmaceutical marketing by scaling personalized content development and delivery and optimizing processes. But it must be deployed responsibly, with clear guardrails to ensure compliance.
We’re proud to be a Diamond Partner for Fierce Pharma Engage 2025! With its unique structure, Engage 2025 fosters meaningful cross-collaboration across four specialized communities—offering educational sessions, strategic networking, and thought-provoking discussions designed to drive impact.
Ostro's Kristina Kirby will join industry thought leaders for a dynamic panel discussion on enhancing HCP and consumer engagement with innovative strategies and AI-powered solutions.
.jpg)
As of October 1, 2024, pharmaceutical companies promoting prescription medicines in the UK must adhere to the revised standards outlined in the new Association of the British Pharmaceutical Industry (ABPI) 2024 Code of Conduct.
.svg)